Triomics is a startup based in the United States, most recent round Series B, 3 tracked investors.
Triomics is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
Triomics develops generative AI solutions for oncology, focusing on cancer care operations and research. The company provides a platform that automates clinical trial matching, pre-visit chart review and preparation, and oncology data abstraction for registries, quality improvement and operational work.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.